Posted inComunicati
Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE Milestones underscore clinical progress and strengthen commercial foundation LOS GATOS, Calif.,…









